机构：[1]State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China [2]Cancer Center, the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, P. R. China
Background: The anti-tumor properties of curcumin have been demonstrated for many types of cancer. However, a systematic functional and biological analysis of its target proteins has yet to be fully documented. The aim of this study was to explore the underlying mechanisms of curcumin and broaden the perspective of targeted therapies. Methods: Direct protein targets (DPTs) of curcumin were searched in the DrugBank database. Using the STRING database, the interactions between curcumin and DPTs and indirect protein targets (IPTs) weres documented. The protein-protein interaction (PPI) network of curcumin-mediated proteins was visualized using Cytoscape. Kyoto Encydopedia of Genes and Genomes (KEGG) pathway enrichment analysis was performed for all curcumin-mediated proteins. Furthermore, the cancer targets were searched in the Comparative Toxicogenomics Database (CTD). The overlapping targets were studied using Kaplan-Meier analysis to evaluate cancer survival. Further genomic analysis of overlapping genes was conducted using the cBioPortal database. Lastly, MIT, quantitative polymerase chain reaction (qPCR), and western blot (WB) analysis were used to validate the predicted results on hepatocellular carcinoma (HCC) cells. Results: A total of five DPTs and 199 IPTs were found. These protein targets were found in 121 molecular pathways analyzed via KEGG enrichment. Based on the anti-tumor properties of curcumin, two pathways were selected, including pathways in cancer (36 genes) and HCC (22 genes). Overlapping with 505 HCC-related gene sets identified in CTD, five genes (TP53, RB1, TGFB1, GSTP1, and GSTM1) were finally identified. High mRNA levels of TP53, RBI, and GSTM1 indicated a prolonged overall survival (OS) in HCC, whereas elevated mRNA levels of TGFB1 were correlated with poor prognosis. The viability of both HepG2 cells and Hep3B cells was significantly reduced by curcumin at concentrations of 20 or 30 mu M after 48 or 72 h of culture. At a concentration of 20 mu M curcumin cultured for 48 h, the expression of TGFB1 and GSTP1 in Hep3B cells was reduced significantly in qPCR analysis, and reduced TGFB1 protein expression was also found in Hep3B cells.
基金：
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81873147]; High Level University Project of Guangzhou University of Chinese Medicine [A1-AFD018171Z11069]
第一作者机构：[1]State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Zhao Yuanyuan,Tao Jiahao,Chen Zhuangzhong,et al.Functional drug target disease network analysis of gene-phenotype connectivity for curcumin in hepatocellular carcinoma[J].PEERJ.2021,9:doi:10.7717/peerj.12339.
APA：
Zhao, Yuanyuan,Tao, Jiahao,Chen, Zhuangzhong,Li, Suihui,Liu, Zeyu...&Zhai, Linzhu.(2021).Functional drug target disease network analysis of gene-phenotype connectivity for curcumin in hepatocellular carcinoma.PEERJ,9,
MLA：
Zhao, Yuanyuan,et al."Functional drug target disease network analysis of gene-phenotype connectivity for curcumin in hepatocellular carcinoma".PEERJ 9.(2021)
